DGAP-News: Andera Partners / Key word(s): Financing Andera Partners supports TargED Biopharmaceuticals in €39 million Series A financing to bring groundbreaking thrombolytic treatment to patients 22.02.2022 / 09:30 The issuer is solely responsible for the content of this announcement. PRESS RELE.
/PRNewswire/ TargED Biopharmaceuticals ("TargED"), a private biotechnology company focused on developing improved treatments for thrombotic diseases, today.